SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-24-035531
Filing Date
2024-02-14
Accepted
2024-02-14 11:14:48
Documents
1
Group Members
QVT FINANCIAL GP LLCQVT FINANCIAL INVESTMENT CAYMAN LTD.QVT ROIV HLDGS OFFSHORE LTD.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d790270dsc13ga.htm SC 13G/A 88705
  Complete submission text file 0001193125-24-035531.txt   90426
Mailing Address 888 SEVENTH AVENUE 43RD FLOOR NEW YORK NY 10106
Business Address 888 SEVENTH AVENUE 43RD FLOOR NEW YORK NY 10106 212-705-8800
QVT Financial LP (Filed by) CIK: 0001290162 (see all company filings)

IRS No.: 113694008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE, 2 CHURCH STREET HAMILTON HM11 D0 HM11 441-295-5950
Roivant Sciences Ltd. (Subject) CIK: 0001635088 (see all company filings)

IRS No.: 981173944 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: SC 13G/A | Act: 34 | File No.: 005-93291 | Film No.: 24634247
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)